Resource Library

Innovation in Alzheimer’s disease research is accelerating—yet progress remains paradoxically constrained.  

This new Insights Hub report from Syneos Health® unpacks three critical tensions shaping today’s clinical trials:  

• How expanded diagnostics are complicating recruitment 

• Why earlier interventions can blur efficacy signals 

• How decentralization both widens access and increases caregiver burden 

Drawing on the expertise of neuroscience leaders, the piece outlines pragmatic solutions sponsors can implement now to reduce screen failures, strengthen data integrity and design trials that truly move the field forward. 

Download the full report to learn how leading sponsors are rethinking trial design to overcome these paradoxes and deliver measurable impacts in Alzheimer’s disease.